Saxagliptin
ONGLYZA
DPP-4 Inhibitor (Antidiabetic)
NADAC/unit
$1.3427
No Shortage
Tier 1: 10.3%
3 Manufacturers
6 ANDAs
Saxagliptin and metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical S....
vs. brand ONGLYZA: Generic saves up to 87% per unit
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
AUROBINDO PHARMA LTDGLENMARK PHARMACEUTICALS LTDMYLAN PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.